CS Paper Radar

Emergence of Transfer Learning towards Specific Identification of Alzheimer's Disease A Prospective Approach

Soumik Podder, Chandramouli Haldar

cs.CV cs.DL ·submitted 2026-08-13 02:01 UTC · v1
published

Abstract

Worldwide, millions of senior citizens are suffering from Alzheimer disease abbreviated as AD, a well- versed form of dementia. AD is featured by amnesia, intellectual disability, and difficulty with consciousness. DL and ML models are undoubtedly explored to identify AD related patterns on large dimensional neuroimaging data but they need global optimization and are suffering from overfitting issue that might yield dissatisfactory result in testing data set. DL overcomes the issue by convolution of input image with kernel but any sudden change in the MRI image or human manipulation, limited pre- processing of the images can mislead CNN in achieving highly accurate detection. Transfer Learning (TL) has proved itself in AD diagnosis by utilizing pre-trained models on large data sets to guide novice model in a new neuroimaging dataset. This review provides an inclusive glimpse of TL implication in classification, identification including the conversion of AD. Keeping in view, we have assessed the strengths and limitations of TL in improvising diagnostic accuracy even with limited data. The uniqueness of the present review is the incorporation of explainable AI in TL based AD diagnosis system. Finally, it can be claimed that the review will guide the new re-searchers in the area of TL induced neurodegenerative disease detection.

Journal ref
2025 AI-Driven Smart Healthcare for Society 5.0, Kolkata, India, 2025
DOI
10.1109/IEEECONF64992.2025.10962879

Closest papers

Nearest neighbours by meaning across the whole index.

A comparison of CNN architectures for Alzheimer's disease detection in single-view MRI scans

eess.IV cs.CVcs.LG ·2026-08-12 ·Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos
publishedbenchmark similarity 0.75
Abstract · Accepted at SPIE Optics + Photonics 2026 for oral presentation. 14 pages, 7 figures, 8 tables

Alzheimer's disease is a leading cause of death with no cure. Therefore, early detection is critical to slow progression and preserve quality of life. Diagnosis relies on medical history, cognitive tests, physical exams, and MRI brain scans, making deep learning suitable for Alzheimer's classification. This work proposes a benchmark that evaluates ten different convolutional neural network (CNN) architectures (including ResNet, DenseNet, MobileNet, EfficientNet, and VGG family models) under the same held-out test split protocol. A two-stage transfer learning and full fine-tuning pipeline is introduced to perform training using a class-balanced subset (3,900 images) derived from the OASIS medical imaging dataset, comprising 86,437 single-view MRI brain scans labeled into four classifications of Alzheimer's disease: Non-Demented, Very Mild Dementia, Mild Dementia, and Moderate Dementia. The best results were achieved by VGG16, with a 0.9637 validation accuracy and a 0.9533 test accuracy score. A key finding documented in this work is the difficulty of classifying the transition from Non-Demented to Very Mild Demented stages, observed consistently across all ten architectures.

0.28

A Multimodal Explainable Deep Learning Framework for Alzheimer's Disease Diagnosis using 3D Magnetic Resonance Imaging and Clinical Data

cs.CV stat.ML ·2026-09-11 ·Yusuf Brima, Marcellin Atemkeng, Lakshmana Rao Namamula, Antoine Vacavant
similarity 0.74
Abstract

Dementia is a major and growing global health burden, with Alzheimer's disease (AD) accounting for most cases. Timely and accurate diagnosis is central to managing this burden and increasingly depends on integrating complementary clinical and imaging information. Multimodal deep learning can combine these modalities for AD diagnosis, but how its explanations behave across modalities, fusion strategies, and cohorts remains unclear. We developed an explainable multimodal framework pairing a 3D CNN encoder for T1-weighted MRI with a feedforward network for harmonized clinical and demographic data, comparing varied model setups on three-way and pairwise diagnostic tasks using 6,479 internal records from the ADNI and 1,703 independent records from the OASIS-3. On ADNI, the tabular-only model achieved the highest three-class AUC-ROC of 0.879 and best discriminated cognitively normal (CN) versus mild cognitive impairment (MCI; 0.903), while cross-attention performed best for MCI versus AD (0.861); CN versus AD was highly discriminative overall. On OASIS-3, the vision-only model performed best (three-class AUC-ROC 0.910); CN versus MCI remained difficult, and no fusion strategy consistently outperformed single modalities across tasks and cohorts. SHAP and Integrated Gradients identified the MMSE as the dominant tabular feature in both cohorts, with global feature rankings agreeing strongly in ADNI ($ρ=0.94$) and OASIS-3 ($ρ=0.96$); CAM-based explanations, however, changed with model configuration and cohort. These findings show that multimodal performance and explanations are task, modality, fusion, and cohort-dependent: a dominant cognitive signal persisted across cohorts, but feature contributions and CAM explanations did not, underscoring the need to evaluate explainability under cohort shift rather than as a stable, intrinsic property.

0.10

A Generalizable Feature Extractor for Alzheimer's-Related Brain MRI Tasks

cs.CV q-bio.QM ·2026-09-04 ·Reza Rajabli, D. Louis Collins
similarity 0.74
Abstract · 26 pages (excluding the references section), 7 figures (excluding sub-figures)

When there is not enough labeled data to properly train deep learning models, transfer learning can help. We still do not fully understand how effective it is in neuroimaging, especially for Alzheimer's disease research. It is also not clear if these transferred models can work on new datasets without being retrained for each specific task. We evaluate whether a compact, supervised pretrained model can serve as a reusable foundation model for downstream neuroimaging tasks. We freeze the 7.18 million weights of a 3D CNN previously trained for brain-age prediction, and adapt it to each task using Low-Rank Adaptation (LoRA), requiring only ~1% additional trainable parameters. We evaluate generalizability in six experiments. Adapting the model to classify cognitively normal versus Dementia on ADNI gave an AUC of 0.964 on held-out folds (Experiment #1). Applying that adapted model unchanged to OASIS-3, with no retraining, gave an AUC of 0.871 (Experiment #2). Reusing its output logit together with age and a cognitive score distinguished stable from progressing MCI with an AUC of 0.828 (Experiment #3). Adapting the same backbone to predict amyloid positivity from structural MRI gave an AUC of 0.804 (Experiment #4). Finally, the same approach estimated ICV-normalized hippocampal and white matter hypointensity volumes directly from the T1w image, with R^2 of 0.80 and 0.91 respectively, tasks normally addressed with much larger U-Net networks (Experiments #5 and #6). A compact model supervised on brain age can therefore serve as a reusable backbone, adapting to each task with ~1% additional parameters and transferring to an unseen cohort without any training. Our findings suggest that a carefully trained brain age model can serve as an effective foundation model for Alzheimer's related tasks, even under strict data constraints.

0.18

EigenGradCAM with AugSmooth: Enhancing Explainability and Precision in Multi-Stage Alzheimer's Disease Detection

cs.CV ·2026-10-23 ·Arsham Azam, Sagar Ashraf, Tayyaba Farhat, Rasikh Ali, Sheeraz Akram
similarity 0.69
Abstract

Alzheimer's disease (AD) is a progressive neurological disorder associated with memory loss, cognitive decline, and behavioral disturbances. Early and accurate diagnosis is essential, yet MRI-based deep learning models often lack interpretability, limiting their clinical use. This study presents an explainable deep learning approach for four-class AD staging using 2D axial MRI images. The method combines eigenvector-based Grad-CAM with gradient smoothing to improve saliency localization and heatmap stability. Principal component analysis is applied to gradient-weighted convolutional layers, while Gaussian noise is added to saliency weights before decomposition. To address class imbalance in the Moderate Dementia category, Wasserstein Generative Adversarial Network with Gradient Penalty (WGAN-GP) generates synthetic samples to balance the four-stage training distribution. Custom convolutional neural networks are trained on the Best Alzheimer MRI Dataset, achieving 97.2% test accuracy, 97.0% balanced accuracy, and a Matthews correlation coefficient of 0.944. The area under the ROC curve ranges from 0.96 to 0.99 across classes. Generated heatmaps highlight the hippocampus and entorhinal cortex, regions associated with Alzheimer's disease biomarkers. These findings suggest that the proposed approach combines strong classification performance with improved model interpretability, although further clinical validation is needed.

0.21

Anatomical Grounding and Leakage-Aware Multimodal Contrastive Learning for Alzheimer's Disease Classification from Structural MRI

cs.CV cs.AI ·2026-09-14 ·Paul-Gabriel Nicolae, Irina Georgiana Mocanu
theory similarity 0.68
Abstract · 13 pages, 4 figures

Deep networks trained on structural MRI for Alzheimer's disease (AD) staging often reach reasonable accuracy while attending to anatomically irrelevant regions, and multimodal models that add clinical tables frequently rely on variables that were used to assign the diagnostic label in the first place. We study both issues with a deliberately lightweight slice-based encoder (ResNet18 with a one-layer Transformer over slices) on 1,075 baseline T1-weighted scans from ADNI-1. First, we use FastSurfer segmentations as an anatomical reference: YOLOv8 models trained on segmentation-derived labels localize Alzheimer-relevant structures with mAP_50 above 0.96, and a Grad-CAM comparison shows that the image-only classifier frequently attends to the skull, orbits and background. Second, we adapt a CLIP-style image - tabular contrastive framework and organize ADNIMERGE variables along a label-leakage spectrum. Fusion with cognitive scores yields 87.3% three-way accuracy, which we treat as a leakage-driven upper bound rather than an imaging result; fusion with regional volumes yields 73.0%. We observe that the choice of contrastive target changes what the image encoder learns: on MCI vs. CN, the image-only head reaches 52.4% when the encoder is aligned to cognitive scores and 73.8\% when aligned to volumes, although no tabular input is used at inference. Third, restricting the input to a per-subject crop of the medial temporal lobe raises image-only three-way accuracy from 58.7% to 65.1%. All results come from single runs on a small balanced test set, and we report confidence intervals and the protocol differences that prevent direct comparison with published numbers.

0.16

Cross-disorder Learning of Imaging-derived Joint Mophometric Markers in Alzheimer's and Parkinson's Diseases

cs.LG q-bio.QMq-bio.NC ·2026-10-19 ·Yuji Zhao, Boris Gutman
code/datahot direction similarity 0.68
Abstract

As two most prevalent neurodegenerative diseases (NDDs), Alzheimer's disease (AD) and Parkinson's disease (PD) shared commonalities both in symptomology and pathophysiology. However, to what extent and in what way these two distinct disorders overlap remain underexplored. In this study, we propose an explicit, interpretable and spatially adaptive transfer learning framework to elucidate the morphometric biomarkers linked to AD and PD. We applied such high-dimensional machine learning model to two most popular open-source neuroimaging datasets, i.e., Alzheimer's Disease Neuroimaging Initiative (ADNI) and Parkinson's Progression Markers Initiative (PPMI). On the one hand, our cross-disorder classifier revealed neuro-anatomical alteration patterns well aligning with previous neuroimaging research findings and underscoring patients' clinical presentations. On the other hand, the spatially adaptive trained classifier using shared prior achieved statistically superior diagnostic performance compared to respective individual models, which further highlights the cross-disorder framework's efficacy on modeling limited-size datasets across disease domains.

0.37

Improving the Clinical Generalizability of Machine Learning-Based Alzheimer's Disease Detection Across Domains and Modalities: A Comprehensive Review

eess.AS ·2026-11-05 ·Yingchao Huang, Yuhan Su, Xin Wang, Shanshan Yao
published similarity 0.66
Abstract · This paper has been accepted by the Journal of Alzheimer's Disease

Objective: This review aims to provide a comprehensive synthesis of domain adaptation (DA) and domain general- ization (DG) strategies for AD detection. It focuses on their potential to improve the robustness, generalizability, and clinical reliability of ML-based diagnostic systems. Methods: We conduct a comprehensive scoping review of existing DA and DG approaches across multiple data modalities. The reviewed studies are organized according to data modality, algorithmic framework, adaptation strat- egy, clinical relevance, and reported cross-domain performance. Key methodological trends, performance gains, limitations, and remaining challenges are analyzed to identify future research directions. Results: DA and DG approaches have demonstrated encouraging improvements in cross-domain performance and model robustness. Emerging modalities, such as speech-based approaches, EEG and eye-tracking data, show great po- tential for early, accessible, and non-invasive cognitive assessments. However, important limitations remain, including insufficient external validation, limited interpretability, computational complexity, privacy concerns, and challenges in scaling to routine clinical practice. Conclusion: DA and DG provide important methodological pathways for developing more generalizable ML-based systems for AD detection. Future research should prioritize explainable, computationally efficient, privacy-preserving, and clinically validated DA/DG techniques. Strengthening these aspects will be essential for translating robust AI- based AD detection tools into clinically deployable solutions.

0.22

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

cs.CV ·2026-10-24 ·Hafija Aktar, Molly Croes, Frank S. Menniti, Abdeltawab Hendawi
dataset similarity 0.65
Abstract · 12 pages, 9 tables, 3 figures. Submitted to Biomedical Signal Processing and Control

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.

0.20